U.S. Life Sciences Stock News

Insmed Incorporated recently reported a third quarter net loss of US$370.02 million but raised its 2025 global ARIKAYCE revenue guidance to between US$420 million and US$430 million, signifying higher growth expectations for the product. This updated revenue outlook comes despite an increase in net loss for both the quarter and year-to-date, highlighting expansion in ARIKAYCE demand even as overall losses continue to widen. We'll examine how the improved ARIKAYCE revenue forecast shapes...

Kite Realty Group Trust (KRG) just wrapped up an eventful stretch, rolling out third quarter earnings, issuing fresh net income guidance for 2025, increasing its fourth quarter dividend by 7%, and completing a significant share buyback. See our latest analysis for Kite Realty Group Trust. While Kite Realty Group Trust’s latest share buyback, updated guidance, and dividend boost have caught investors’ attention, the stock’s momentum has yet to shift meaningfully. The year-to-date share price...

Federal Agricultural Mortgage, fresh off announcing higher net income and earnings per share for the third quarter and year-to-date period, is also rewarding shareholders with affirmed dividends across its common and preferred stock classes. These actions highlight consistent financial momentum and a commitment to shareholder returns. See our latest analysis for Federal Agricultural Mortgage. After the encouraging earnings and dividend affirmations, Federal Agricultural Mortgage’s share price...

LiveWire Group, Inc. recently announced its third-quarter 2025 financial results, updated its full-year operating loss guidance to US$72 million–US$77 million, and showcased several new electric motorcycles and product initiatives at the EICMA International Motorshow in Milan. The company's expanded product lineup, including the European debut of the S4 Honcho and the unveiling of a new maxi-scooter developed with KYMCO, highlights a shift toward broader market accessibility and innovation...

Earlier this week, Johnson & Johnson announced it received U.S. FDA approvals for DARZALEX FASPRO® as a single-agent treatment for high-risk smoldering multiple myeloma and for CAPLYTA as an adjunctive therapy in major depressive disorder. The DARZALEX FASPRO® approval marks the first FDA-authorized therapy for early-stage HR-SMM, and expands Johnson & Johnson's offerings in oncology and psychiatric medicines based on robust Phase 3 trial data. We'll explore how these recent FDA approvals...

Arrowhead Pharmaceuticals is approaching a key FDA decision on November 18, 2025, for its RNAi therapy Plozasiran targeting familial chylomicronemia syndrome, following strong efficacy in Phase 3 trials with substantial reduction in triglycerides and pancreatitis risk. Additionally, Novartis has announced a global licensing agreement for development of ARO-SNCA, bringing Arrowhead significant upfront payments and milestone opportunities that strengthen its financial position before potential...

Vornado Realty Trust recently reported its third-quarter 2025 results, achieving a turnaround with net income of US$27.12 million compared to a net loss a year earlier, supported by revenue of US$453.7 million and key gains from property transactions including a master lease with New York University. Investor interest was further fueled by Vornado's strong leasing activity in Manhattan, acquisition and redevelopment plans for 623 Fifth Avenue, and expectations for increased Penn District...

Capital Southwest (CSWC) just posted earnings that topped expectations, completing a busy quarter that included new investments and a $350 million bond raise. The company also declared regular and supplemental dividends for shareholders. See our latest analysis for Capital Southwest. After a strong earnings beat and a successful $350 million bond raise, Capital Southwest’s momentum has started to gain traction. The share price recently saw a modest rebound, up nearly 2% over the past week to...

Janux Therapeutics (JANX) just released its third quarter and nine-month financial results, catching the eye of investors. The company trimmed its quarterly net loss compared to the previous year. However, its net loss for the year to date increased. See our latest analysis for Janux Therapeutics. Janux Therapeutics’ latest earnings update came amid a turbulent period for the stock, with a 1-day share price drop of 7.6%, and a 7-day slide of 7.8%. Even with recent volatility, its 30-day share...

In recent weeks, Carnival Corporation’s Holland America Line announced its 2027-2028 South America and Antarctica cruise season, offering immersive itineraries to landmark destinations like Machu Picchu and the Galapagos Islands with extended sailings aboard Zuiderdam and Oosterdam. This expansion into highly curated and remote cruise offerings highlights the company’s continued focus on unique guest experiences and on broadening appeal to adventure and nature-focused travelers. We’ll...

Brown & Brown, Inc. recently announced its third quarter 2025 results, reporting revenue of US$1.61 billion and net income of US$227 million, alongside an active acquisition outlook according to their CEO's commentary on seeking both domestic and international deals. While revenue increased compared to the prior year, net income saw a slight decline and the company paused share repurchases for this period, completing earlier buybacks totaling over 16.5 million shares. Given the CEO's ongoing...

Nexstar Media Group (NXST) shares edged up slightly today, catching the eye of investors after a mostly flat week and a modest month-long dip. With the company showing stable annual revenue and net income growth, some are revisiting their outlook. See our latest analysis for Nexstar Media Group. Nexstar’s share price has cooled a bit recently, but the bigger picture is hard to ignore. After a strong rally year to date and a 19.7% total shareholder return over the past year, momentum is still...

Dyne Therapeutics reported its third quarter and nine-month financial results for the period ended September 30, 2025, posting a net loss of US$108.04 million for the quarter and US$334.26 million for the nine months. The company is also set to present updates and engage with the investment community at several major healthcare investor conferences through the end of 2025. We'll explore how the widening net loss shapes Dyne Therapeutics' investment narrative amid ongoing engagement with the...

On November 6, 2025, Sunstone Hotel Investors, Inc.'s Board of Directors authorized cash dividends on both its common and preferred stock classes, with dividends payable on January 15, 2026, to stockholders of record as of December 31, 2025, and reaffirmed its 2025 earnings guidance. Sunstone Hotel Investors also reported quarterly financial results that exceeded consensus revenue and funds from operations estimates, pointing to continued operational momentum and the company's focus on...

Crinetics Pharmaceuticals recently announced the U.S. FDA approval and commercial launch of PALSONIFY (paltusotine) for treating adults with acromegaly, reporting early metrics of prescription uptake and field force coverage. This milestone marks Crinetics' transition to a commercial-stage company, supported by a strong cash position expected to fund operations into 2029 and ongoing advances in its clinical pipeline. With early signs of PALSONIFY’s market acceptance, we’ll explore how this...

Alexander & Baldwin, Inc. recently amended its US$450 million revolving credit facility, adding a new term loan facility of up to US$200 million, and raised its 2025 earnings guidance to a range of US$0.95 to US$1 per diluted share. These developments point to a focus on both financial flexibility and growth opportunities, particularly as the company actively searches for acquisitions in Hawaii’s competitive investment market. Let's examine how the creation of this new term loan facility...

Earlier this month, Sally Beauty named Creative Media Marketing (CMM PR) as its new public relations agency of record and launched its Holiday Beauty at Home campaign, featuring affordable at-home beauty solutions, influencer content, and an expanded fragrance lineup through December. The exclusive partnership with the Brandy & Monica "The Boy is Mine" U.S. Tour and renewed brand positioning efforts may boost Sally Beauty's visibility and consumer engagement during the crucial holiday sales...

MPLX LP recently reported third quarter 2025 earnings, showing year-over-year growth with revenue at US$3.62 billion and net income of US$1.55 billion, alongside a 12.5% increase in its quarterly cash distribution to US$1.0765 per common unit. This strong operational and financial update was complemented by an announcement of further share repurchases and a new partnership initiative intended to expand natural gas supply infrastructure in West Texas. To understand the impact of these...

Navigator Holdings reported third quarter 2025 results with revenue rising to US$153.09 million and net income increasing to US$33.16 million, alongside an announced cash dividend of US$0.07 per share and a new US$5.4 million share repurchase program. The company increased its targeted capital return to shareholders to 30% of net income, reflecting confidence in its ongoing earnings strength and policy of rewarding investors through dividends and buybacks. We'll explore how this elevated...

PJT Partners reported record third-quarter and nine-month financial results, with revenue reaching US$447.09 million and net income at US$39.84 million, while the board declared a quarterly dividend of US$0.25 per share payable on December 17, 2025. The firm’s expansion in advisory fee mandates, alongside its top ranking in U.S. restructuring advisory, highlighted its strong position amid a rebound in M&A activity. We’ll explore how the sharp growth in advisory fees and expanded team could...

Wondering if now is the right time to pick up shares of Home Depot? You are not alone, as many investors are keeping a close eye on its valuation and growth story. Recently, Home Depot's stock has seen some turbulence, losing 2.2% over the past week and 3.3% in the last month. This has contributed to a 4.5% slide year-to-date. Much of this movement is happening as the company navigates changes in consumer spending and shifting trends in the DIY market. Recent headlines have highlighted the...

Southwest Gas Holdings (SWX) shares have seen steady movement this month, with investors carefully watching the company’s financial performance and broader utility sector trends. Year to date, the stock has climbed 14%, suggesting moderate market confidence. See our latest analysis for Southwest Gas Holdings. Southwest Gas Holdings has posted a 1-year total shareholder return of just over 10%, with steady upward momentum since the start of 2024. Recent share price gains reflect renewed...

Penumbra (PEN) shares have been performing steadily in recent weeks, with the stock up about 17% over the past week and around 3% for the month. Investors are watching closely to see if this momentum continues as the broader healthcare sector evolves. See our latest analysis for Penumbra. Momentum has definitely picked up for Penumbra lately, with the share price jumping over 17% in the past week and adding to a healthy year-to-date gain. Even after some ups and downs, Penumbra’s 12.6% total...

Copart (CPRT) has continued to attract investor attention given its performance over the month, with shares recently closing at $40.51. The company’s business metrics and year-to-date moves are fueling new conversations about current valuation. See our latest analysis for Copart. After a strong run in previous years, Copart’s share price momentum has cooled in 2024, with a 1-day gain of 1.33% offering little relief from its year-to-date decline of 28.07%. Despite this, long-term shareholders...